Genmab | GEN - Action





Action Changement Date
Agios Pharmaceuticals USD 35.75M 665K 2026-06
Almirall EUR 178.13M 1.54M 2025-12
Amarin USD 164.07M 19.51M 2026-06
Amgen USD 6.22B 34M 2026-06
argenx SE USD 473.53M 132.91M 2025-12
AstraZeneca USD 6.93B 362M 2026-06
Bayer EUR 11.97B 43M 2026-06
BioMarin Pharmaceutical USD 1.78B 509.3M 2026-06
Demant DKK 2.62B 78M 2025-12
Exelixis USD 28.73M 2.12M 2026-06
Fresenius Medical Care EUR 2.33B 28.84M 2026-06
Genmab DKK 21M 8M 2026-03
GlaxoSmithKline GBP 6.16B 233M 2026-03
GN Store Nord DKK 2.31B 62M 2025-12
GRIFOLS EUR 3.49B 34M 2026-06
Hikma Pharmaceutical USD 1.11B 24M 2025-12
Insmed USD 142.38M 9.48M 2026-06
Lakefront Biotherapeutics EUR 17.69M 4.8M 2026-03
Lonza CHF 1.68B 163M 2025-12
Merck EUR 4.78B 220M 2026-03
Novartis USD 6.22B 66M 2026-06
Regeneron Pharmaceuticals USD 3.08B 19.3M 2026-06
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 24.12B 620M 2026-06
UCB EUR 1.31B 173M 2024-12